Members
Adrian Bighea, MD, PhD
Curriculum vitae

Personal Informations
Name: Adrian Costin Bighea
Official address:
University of Medicine and Pharmacy
4 Petru Rares str.
Craiova, Dolj
ROMANIA
Work Phone: 0040 251 502296
Fax: 0040 251 502296
E-mail: bighea@fizio.ro
Marital status: married, 2 children
Nationality: Romanian
Date and place of birth: 16 May 1955, Sibiu, Romania
Education
- 1981: Medical Doctor, Faculty of Medicine, University of Craiova, Romania
- 2004: Ph.D., Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania
Career/Employment
- 1981-1988: Medical Doctor Emergency Clinical Hospital of Craiova
- 1988-1991: Resident in Physical Medicine and Rehabilitation, Emergency Clinical Hospital of Craiova
- 1991-2007: Specialist in Physical Medicine and Rehabilitation, Emergency Clinical Hospital of Craiova
- 1992-2002: Teaching Assistant University of Medicine and Pharmacy of Craiova
- 2002-2007: Lecturer – University of Medicine and Pharmacy of Craiova
- 2007: Assistant Professor – Universityof Medicine and Pharmacy of Craiova
Specialization
- Physical Medicine and Rehabilitation
Membership of Professional Societies
- Romanian Society of Physical and Rehabilitation Medicine: board member
- International Society of Physical and Rehabilitation Medicine: member
- European Society of Physical and Rehabilitation Medicine: member
Publications
- Number of papers in refereed journals: 42
- Number of communications to scientific meetings: 68
- Books: 5
Experience in Clinical Trials
- An Open Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain due to Osteoarthritis of the Knee.
- A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Ascending Dose Study to Assess the Activity, Safety and Tolerability of 2 Doses of AZD9056 for 4 Weeks in Patients with Active Rheumatoid Arthritis Receiving Methotrexate or Sulphasalazine.
- A placebo-controlled, double-blind, Phase II study exploring the safety, tolerability, and efficacy of a 4-week course of INCB003284 (100 mg bid) in subjects with active rheumatoid arthritis while receiving methotrexate.
- Phase 2 Randomized, Double-Blind, Study of the Safety, Pharmacokinetics, and Pharmaco-dynamics of TRU-015 Administered Intravenously in Subjects with Rheumatoid Arthritis
Current research interests:
- Low back pain
- Viscosuplimentation therapy in knee osteoarthritis